ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2022

Poloxamer-linked prodrug of a topoisomerase I inhibitor SN22 shows efficacy in models of high-risk neuroblastoma with primary and acquired chemoresistance.

Ivan S Alferiev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.